SI-BONE, Inc. Common Stock (SIBN) Stock Price

SIBNStock

$19.68+30.33%52W

Market Cap$872.79M

P/E—

PEG Ratio—

Div yield—

Beta0.64

SIBN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)26.48%

Price vs S&P 500 (4W)7.99%

VGM Score58.69

Book Value / Share (Quarterly)$4.08

P/TBV (Annual)7.39x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)23.60%

Cash Flow / Share (Quarterly)$-0.10

Price vs S&P 500 (YTD)-12.13%

Gross Margin (TTM)79.53%

Net Profit Margin (TTM)-6.85%

EPS (TTM)$-0.33

10-Day Avg Trading Volume0.61M

EPS Excl Extra (TTM)$-0.33

Revenue Growth (5Y)22.31%

EPS (Annual)$-0.44

ROI (Annual)-8.87%

Gross Margin (Annual)79.57%

Net Profit Margin (5Y Avg)-35.89%

Cash / Share (Quarterly)$3.27

Revenue Growth QoQ (YoY)15.18%

ROA (Last FY)-7.92%

Revenue Growth TTM (YoY)15.30%

EBITD / Share (TTM)$-0.26

ROE (5Y Avg)-31.84%

Operating Margin (TTM)-8.31%

Cash Flow / Share (Annual)$-0.21

P/B Ratio4.84x

P/B Ratio (Quarterly)3.97x

Net Income / Employee (Annual)$-50,300

EV / Revenue (TTM)4.14x

Net Interest Coverage (TTM)-75.63x

ROA (TTM)-6.07%

EPS Incl Extra (Annual)$-0.44

Current Ratio (Annual)8.55x

Quick Ratio (Quarterly)7.37x

3-Month Avg Trading Volume0.57M

52-Week Price Return30.33%

Revenue / Employee (TTM)$568,100

Tangible BV / Share (Quarterly)$4.30

P/S Ratio (Annual)4.39x

Asset Turnover (Annual)0.84x

52-Week High$21.89

Operating Margin (5Y Avg)-36.39%

EPS Excl Extra (Annual)$-0.44

CapEx CAGR (5Y)26.87%

26-Week Price Return36.38%

Quick Ratio (Annual)7.03x

13-Week Price Return13.23%

Total Debt / Equity (Annual)0.20x

Current Ratio (Quarterly)9.15x

Enterprise Value$884.53M

Revenue / Share Growth (5Y)13.14%

Asset Turnover (TTM)0.89x

Book Value / Share Growth (5Y)-4.77%

Revenue / Employee (Annual)$534,400

Inventory Turnover (Annual)1.35x

Pretax Margin (Annual)-9.41%

Cash / Share (Annual)$3.39

3-Month Return Std Dev35.19%

Gross Margin (5Y Avg)82.20%

Net Income / Employee (TTM)$-38,900

ROE (Last FY)-10.65%

Net Interest Coverage (Annual)-32.63x

EPS Basic Excl Extra (Annual)$-0.44

Receivables Turnover (TTM)7.69x

Total Debt / Equity (Quarterly)0.20x

EPS Incl Extra (TTM)$-0.33

Receivables Turnover (Annual)7.00x

ROI (TTM)-6.86%

P/S Ratio (TTM)4.13x

Pretax Margin (5Y Avg)-35.89%

Revenue / Share (Annual)$4.68

Tangible BV / Share (Annual)$2.83

Price vs S&P 500 (52W)14.80%

Year-to-Date Return-0.20%

5-Day Price Return-2.09%

EPS Normalized (Annual)$-0.44

ROA (5Y Avg)-21.75%

Net Profit Margin (Annual)-9.41%

Month-to-Date Return4.68%

Cash Flow / Share (TTM)$-1.05

EBITD / Share (Annual)$-0.39

Operating Margin (Annual)-11.11%

LT Debt / Equity (Annual)0.20x

P/CF (TTM)355.94x

ROI (5Y Avg)-24.91%

LT Debt / Equity (Quarterly)0.20x

EPS Basic Excl Extra (TTM)$-0.33

P/TBV (Quarterly)4.18x

P/B Ratio (Annual)4.82x

Inventory Turnover (TTM)1.20x

Pretax Margin (TTM)-6.85%

Book Value / Share (Annual)$4.07

Price vs S&P 500 (13W)10.55%

Beta0.64x

Revenue / Share (TTM)$4.80

ROE (TTM)-8.23%

52-Week Low$11.48

vGradeD

gGradeB

mGradeB

vgmGradeC

SIBN Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 3, 2026	-$0.15	-$0.09	+39.92%(+$0.06)
Q1 2026	May 11, 2026	-$0.19	-$0.10	+47.76%(+$0.09)
Q4 2025	Feb 23, 2026	-$0.13	-$0.04	+68.14%(+$0.09)
Q3 2025	Nov 10, 2025	-$0.17	-$0.11	+33.33%(+$0.06)
Q2 2025	Aug 4, 2025	-$0.18	-$0.14	+21.13%(+$0.04)

SIBN Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.20

4.19

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About SI-BONE, Inc. Common Stock

SI-BONE Inc. develops and markets minimally invasive surgical implants focused on spine and orthopedic conditions, including its flagship iFuse system for sacroiliac joint fusion. The company's proprietary titanium implants and surgical instruments address high-prevalence conditions such as spinal deformity, degeneration, and pelvic trauma. With operations in the U.S. and internationally, SI-BONE serves the growing orthopedic surgery market through its specialized implant portfolio.

SIBN Next Earnings Report

Report dateNov 9, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.13

Revenue estimate$55.31M

Also reporting on Nov 9, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

SIBN Insider Transactions

SellOct 12, 2026
FRANCIS LAURA A.
Chief Executive Officer
Shares: 38,006Value: $762,013
SellOct 5, 2026
MAHESHWARI ANSHUL
Chief Operating Officer
Shares: 5,049Value: $94,079
SellOct 2, 2026
PISETSKY MICHAEL A
Officer
Shares: 3,133Value: $56,918
SellOct 1, 2026
DUNN JEFFREY W
Director
Shares: 20,000Value: $369,400
SellSep 1, 2026
DUNN JEFFREY W
Director
Shares: 20,000Value: $378,160

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for October 2026

Companies in Related Industries

ENOVEnovis CorporationOrthopedic & Prosthetic Devices
CDRECadre Holdings, Inc.Orthopedic & Prosthetic Devices
STAAStaar Surgical CoOphthalmic Goods
CBLLCeriBell, Inc. Common StockElectromedical Equipment
KODKEASTMAN KODAK COMPANYPhotographic Equipment & Supplies
INMDInMode Ltd. Ordinary SharesElectromedical Equipment
TRNSTranscat IncInstruments for Measuring
FEIMFrequency Electronics, Inc.Instruments for Measuring

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.2

Buy

Consensus rating

52-Week Range

Low$11.48

High$21.89